Fox Run Management L.L.C. Boosts Position in LifeStance Health Group, Inc. $LFST

Fox Run Management L.L.C. raised its holdings in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) by 19.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 51,653 shares of the company’s stock after buying an additional 8,250 shares during the period. Fox Run Management L.L.C.’s holdings in LifeStance Health Group were worth $267,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Teacher Retirement System of Texas purchased a new position in shares of LifeStance Health Group in the 1st quarter valued at $130,000. Xponance Inc. acquired a new stake in LifeStance Health Group in the 1st quarter valued at $69,000. Victory Capital Management Inc. raised its position in LifeStance Health Group by 2,599.0% in the first quarter. Victory Capital Management Inc. now owns 370,598 shares of the company’s stock valued at $2,468,000 after purchasing an additional 356,867 shares during the period. Jennison Associates LLC lifted its stake in shares of LifeStance Health Group by 2.1% during the first quarter. Jennison Associates LLC now owns 8,255,236 shares of the company’s stock worth $54,980,000 after purchasing an additional 168,856 shares in the last quarter. Finally, Choreo LLC boosted its position in shares of LifeStance Health Group by 6.4% in the first quarter. Choreo LLC now owns 27,420 shares of the company’s stock worth $183,000 after buying an additional 1,661 shares during the period. Institutional investors and hedge funds own 85.50% of the company’s stock.

LifeStance Health Group Stock Performance

Shares of LFST opened at $6.31 on Friday. The firm has a market cap of $2.45 billion, a price-to-earnings ratio of -210.33 and a beta of 1.15. The company has a quick ratio of 1.48, a current ratio of 1.58 and a debt-to-equity ratio of 0.18. The business’s 50 day moving average is $5.38 and its two-hundred day moving average is $5.27. LifeStance Health Group, Inc. has a 52-week low of $3.74 and a 52-week high of $8.30.

LifeStance Health Group (NASDAQ:LFST) last released its quarterly earnings results on Thursday, November 6th. The company reported $0.02 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. The business had revenue of $363.81 million during the quarter, compared to the consensus estimate of $355.06 million. LifeStance Health Group had a negative net margin of 0.67% and a negative return on equity of 0.62%. The business’s quarterly revenue was up 16.3% compared to the same quarter last year. During the same quarter last year, the company earned ($0.02) earnings per share. LifeStance Health Group has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. Analysts forecast that LifeStance Health Group, Inc. will post -0.18 EPS for the current fiscal year.

Insider Transactions at LifeStance Health Group

In other news, major shareholder Silversmith Partners I. Gp, Llc sold 3,592,357 shares of the business’s stock in a transaction dated Monday, August 18th. The shares were sold at an average price of $5.07, for a total value of $18,213,249.99. Following the completion of the sale, the insider owned 14,324,197 shares of the company’s stock, valued at approximately $72,623,678.79. The trade was a 20.05% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Summit Partners L. P sold 8,407,643 shares of the company’s stock in a transaction dated Monday, August 18th. The shares were sold at an average price of $5.07, for a total transaction of $42,626,750.01. Following the completion of the sale, the insider owned 33,524,715 shares in the company, valued at approximately $169,970,305.05. This trade represents a 20.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 20,407,643 shares of company stock valued at $103,466,750. Insiders own 3.20% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on LFST shares. BTIG Research raised their target price on LifeStance Health Group from $8.00 to $9.00 and gave the company a “buy” rating in a report on Thursday, November 6th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of LifeStance Health Group in a research report on Wednesday, October 8th. BMO Capital Markets initiated coverage on shares of LifeStance Health Group in a research note on Thursday. They set an “outperform” rating and a $8.00 price objective on the stock. Wall Street Zen cut shares of LifeStance Health Group from a “buy” rating to a “hold” rating in a research report on Saturday, October 11th. Finally, UBS Group raised their price target on shares of LifeStance Health Group from $9.00 to $10.00 and gave the company a “buy” rating in a report on Friday, November 7th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $9.00.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.